A Mid-Cap Opportunity In “Wet AMD”
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard to generate.”
“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.
New stocks to watch in 2021.
“When it comes to investing in biotech penny stocks, there are some ways to dramatically increase your chances of success and to give yourself a good chance of becoming a millionaire or even a multimillionaire in the process.”
Having posted positive returns in July in nine of the last 10 years, with an average July return of 4.8%, the medical devices and health… Read More »This Pharma Stock Has A Great Record Of Returns In July
Tech companies involved in software, AI and e-commerce, and a medical device company that designs innovative injection technologies, are among the new stocks to watch.
When it comes to the future of the biotech industry, the author of today’s article notes that “the aging population ensures that demand for new… Read More »A Trio Of Top Biotech Stock Picks
Perceptive Life Sciences, a fund that has outperformed the market, sold all of its 1 million shares of Novavax in the first few months of 2021 and bought millions more shares of three biopharma/biotech stocks in the same period.
Examining four oncology stocks that could be smart picks right now.